171 related articles for article (PubMed ID: 15591116)
1. Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chains.
Vuillier F; Dumas G; Magnac C; Prevost MC; Lalanne AI; Oppezzo P; Melanitou E; Dighiero G; Payelle-Brogard B
Blood; 2005 Apr; 105(7):2933-40. PubMed ID: 15591116
[TBL] [Abstract][Full Text] [Related]
2. Defective assembly of the B-cell receptor chains accounts for its low expression in B-chronic lymphocytic leukaemia.
Payelle-Brogard B; Magnac C; Alcover A; Roux P; Dighiero G
Br J Haematol; 2002 Sep; 118(4):976-85. PubMed ID: 12199775
[TBL] [Abstract][Full Text] [Related]
3. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis.
Cragg MS; Chan HT; Fox MD; Tutt A; Smith A; Oscier DG; Hamblin TJ; Glennie MJ
Blood; 2002 Nov; 100(9):3068-76. PubMed ID: 12384401
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression.
Huse K; Bai B; Hilden VI; Bollum LK; Våtsveen TK; Munthe LA; Smeland EB; Irish JM; Wälchli S; Myklebust JH
J Immunol; 2022 Nov; 209(10):2042-2053. PubMed ID: 36426942
[TBL] [Abstract][Full Text] [Related]
6. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
[TBL] [Abstract][Full Text] [Related]
7. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia.
Thompson AA; Talley JA; Do HN; Kagan HL; Kunkel L; Berenson J; Cooper MD; Saxon A; Wall R
Blood; 1997 Aug; 90(4):1387-94. PubMed ID: 9269755
[TBL] [Abstract][Full Text] [Related]
8. Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo.
Krysov S; Potter KN; Mockridge CI; Coelho V; Wheatley I; Packham G; Stevenson FK
Blood; 2010 May; 115(21):4198-205. PubMed ID: 20237321
[TBL] [Abstract][Full Text] [Related]
9. Retention and defective assembly of the B-cell receptor in the endoplasmic reticulum of chronic lymphocytic leukaemia B cells cannot be reverted upon CD40 ligand stimulation.
Payelle-Brogard B; Magnac C; Oppezzo P; Dumas G; Dighiero G; Vuillier F
Leukemia; 2003 Jun; 17(6):1196-9. PubMed ID: 12764393
[No Abstract] [Full Text] [Related]
10. Assembly and intracellular transport of the human B cell antigen receptor complex.
Brouns GS; de Vries E; Borst J
Int Immunol; 1995 Mar; 7(3):359-68. PubMed ID: 7794818
[TBL] [Abstract][Full Text] [Related]
11. IL-4 rescues surface IgM expression in chronic lymphocytic leukemia.
Guo B; Zhang L; Chiorazzi N; Rothstein TL
Blood; 2016 Jul; 128(4):553-62. PubMed ID: 27226435
[TBL] [Abstract][Full Text] [Related]
12. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
[TBL] [Abstract][Full Text] [Related]
13. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.
Gordon MS; Kato RM; Lansigan F; Thompson AA; Wall R; Rawlings DJ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5504-9. PubMed ID: 10792036
[TBL] [Abstract][Full Text] [Related]
14. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia.
Astsaturov IA; Matutes E; Morilla R; Seon BK; Mason DY; Farahat N; Catovsky D
Leukemia; 1996 May; 10(5):769-73. PubMed ID: 8656670
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin mu heavy chains do not mediate tyrosine phosphorylation of Ig alpha from the ER-cis-Golgi.
Mielenz D; Ruschel A; Vettermann C; Jäck HM
J Immunol; 2003 Sep; 171(6):3091-101. PubMed ID: 12960335
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the B-cell receptor B29 (CD79b) gene in familial chronic lymphocytic leukemia.
Payelle-Brogard B; Magnac C; Mauro FR; Mandelli F; Dighiero G
Blood; 1999 Nov; 94(10):3516-22. PubMed ID: 10552962
[TBL] [Abstract][Full Text] [Related]
18. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
[TBL] [Abstract][Full Text] [Related]
19. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2.
von Wenserski L; Schultheiß C; Bolz S; Schliffke S; Simnica D; Willscher E; Gerull H; Wolters-Eisfeld G; Riecken K; Fehse B; Altfeld M; Nollau P; Binder M
Leukemia; 2021 Apr; 35(4):1073-1086. PubMed ID: 32826957
[TBL] [Abstract][Full Text] [Related]
20. CD79: a review.
Chu PG; Arber DA
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):97-106. PubMed ID: 11396639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]